Information Provided By:
Fly News Breaks for March 3, 2020
SBBP
Mar 3, 2020 | 07:35 EDT
Craig-Hallum analyst Frank Brisebois initiated coverage of Strongbridge Biopharma with a Buy rating and $7.50 price target.
News For SBBP From the Last 2 Days
There are no results for your query SBBP